Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark A. Velleca currently holds 600,000 shares of Black Diamond Therapeutics, Inc. (BDTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark A. Velleca has been a net seller of BDTX stock. They have purchased $0 and sold $8.9M worth of shares.
Mark A. Velleca's most recent insider trade was on Jan 21, 2026, when they sold 600,000 shares at $0.00 per share.
Mark A. Velleca serves as Executive at Black Diamond Therapeutics, Inc. (BDTX). They have executed 104 insider transactions totaling $8.9M over their tenure at the company.
Mark A. Velleca holds the position of Executive at Black Diamond Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Mark A. Velleca has shown a selling trading pattern, with $0 in total purchases and $8.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark A. Velleca was on Aug 16, 2022, when they sold $1.0M worth of GTHX shares. This transaction involved 80,000 shares at $12.64 per share.
Mark A. Velleca currently owns 600,000 shares of Black Diamond Therapeutics, Inc. (BDTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark A. Velleca's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark A. Velleca has 104 Form 4 filings on record as an insider at Black Diamond Therapeutics, Inc..
Set alerts for Mark A. Velleca and 40,000+ other insiders.